Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$444.87 - $538.88 $389,706 - $472,058
-876 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$387.35 - $450.26 $11,620 - $13,507
-30 Reduced 3.31%
876 $394,000
Q1 2021

Apr 30, 2021

SELL
$314.62 - $411.0 $11,640 - $15,207
-37 Reduced 3.92%
906 $346,000
Q4 2020

Feb 05, 2021

SELL
$246.9 - $321.87 $111,598 - $145,485
-452 Reduced 32.4%
943 $300,000
Q3 2020

Nov 13, 2020

BUY
$232.22 - $282.96 $323,946 - $394,729
1,395 New
1,395 $346,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.4B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Claraphi Advisory Network, LLC Portfolio

Follow Claraphi Advisory Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claraphi Advisory Network, LLC with notifications on news.